Treatment of Depression in Parkinson's Disease Trial

Completed · Phase 2 · Has a placebo group

Conditions studied: Parkinson Disease, Depression

In brief

The goal of this study is to evaluate the effectiveness and safety of two antidepressants--nortriptyline and paroxetine, compared to placebo in patients with Parkinson's disease and depression.

Key facts

Study ID

NCT00062738

Run by

Rutgers, The State University of New Jersey

People needed

52

Starts

2003-06-01

Expected to finish

2009-01-01

Last updated by the study team

2015-11-24

Who can join

Age: 35 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Parkinson's disease without dementia.
• Depression.
• Males or females.

You may not qualify if…

• Psychosis
• Heart block

Where it is running

• Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.